Apexium Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Sell |
1,870
-6
| -0.3% | -$4.68K | 0.08% | 101 |
|
|
2025
Q1 | $1.55M | Buy |
1,876
+956
| +104% | +$789K | 0.09% | 96 |
|
|
2024
Q4 | $711K | Buy |
920
+272
| +42% | +$210K | 0.04% | 131 |
|
|
2024
Q3 | $574K | Buy |
648
+46
| +8% | +$40.8K | 0.04% | 131 |
|
|
2024
Q2 | $545K | Buy |
602
+20
| +3% | +$18.1K | 0.04% | 131 |
|
|
2024
Q1 | $453K | Sell |
582
-10,856
| -95% | -$8.45M | 0.03% | 149 |
|
|
2023
Q4 | $6.67M | Buy |
11,438
+10,842
| +1,819% | +$6.32M | 0.48% | 30 |
|
|
2023
Q3 | $320K | Buy |
596
+3
| +0.5% | +$1.61K | 0.03% | 166 |
|
|
2023
Q2 | $278K | Sell |
593
-60
| -9% | -$28.1K | 0.02% | 181 |
|
|
2023
Q1 | $224K | Buy |
653
+8
| +1% | +$2.75K | 0.02% | 190 |
|
|
2022
Q4 | $236K | Sell |
645
-212
| -25% | -$77.6K | 0.02% | 187 |
|
|
2022
Q3 | $277K | Buy |
+857
| New | +$277K | 0.03% | 159 |
|